• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

Biden July 4 COVID vaccine goal
Health
The U.S. won’t make the President’s July 4 vaccination target. Here’s what that means
By Sy MukherjeeJune 22, 2021
Janet Woodcock, acting commissioner of the U.S. Food and Drug Administration (FDA), listens during a Senate Appropriations Subcommittee hearing in Washington, D.C., U.S., on Thursday, June 10, 2021. The hearing is titled "Fiscal Year 2022 Budget Request for the FDA." Photographer: Al Drago/Bloomberg via Getty Images
Health
Pressure mounts on Biden to nominate permanent FDA head as dissatisfaction with agency grows
By Sy MukherjeeJune 22, 2021
Juneteenth Black diversity officers health inequality
Leadership
3 Black diversity chiefs on how they’ll fight racial inequality in medicine
By Sy MukherjeeJune 18, 2021
Juneteenth Black diversity officers health inequality
Newsletters
Three Black health care diversity officers. One united goal
By Sy MukherjeeJune 17, 2021
The decade-long battle against Obamacare reaches a likely end with new Supreme Court decision
Health
The decade-long battle against Obamacare reaches a likely end with new Supreme Court decision
By Sy MukherjeeJune 17, 2021
COVID delta variant
Health
What you should know about the Delta variant and what it means for reopening
By Sy MukherjeeJune 16, 2021
COVID vaccines heart inflammation
Health
What we know about COVID vaccines, heart inflammation, and its implications for drug makers
By Sy MukherjeeJune 11, 2021
Biogen aducanumab FDA approval
Newsletters
What comes next after the Biogen Alzheimer’s drug approval
By Sy MukherjeeJune 10, 2021
The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019.
Health
Biogen won its controversial Alzheimer’s drug approval. Which drugmakers will see the next big win?
By Sy MukherjeeJune 9, 2021
The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019.
Health
FDA approves Biogen’s controversial Alzheimer’s drug in historic decision
By Sy MukherjeeJune 7, 2021
New Fortune 500 CEOS 2021
Newsletters
The health care companies leading 2021’s Fortune 500 list
By Sy MukherjeeJune 3, 2021
Abortion, Obamacare, and drug approvals: American health care faces a pivotal moment
Newsletters
Abortion, Obamacare, and drug approvals: American health care faces a pivotal moment
By Sy MukherjeeMay 27, 2021
FDA Biogen Alzheimer's Janet Woodcock
Health
President Biden still hasn’t appointed a permanent FDA commissioner. That has big implications for upcoming drug approvals
By Sy MukherjeeMay 25, 2021
COVID vaccines military
Health
The U.S. military had a COVID vaccine skepticism problem. But now it’s seeing a massive jump in shots
By Sy MukherjeeMay 21, 2021
Pharmaceutical Executives Testify At Senate Finance Committee Hearing On Drug Prices
Newsletters
Congress loves a Big Pharma villain. But will that lead to any real policy changes on drug prices?
By Sy MukherjeeMay 20, 2021
1
  • 2
  • 3
  • 4
  • 5
  • 6
...100
Most Popular
Real Estate
The millennial generation is split in 2: an older crowd with boomer-style comfort, a younger set going 'back to the early 1900s'placeholder alt text
By Nick LichtenbergJuly 25, 2026
Middle East
Trump pulls back after Iran crosses his red line as U.S. military breaks two-week streak of airstrikes amid talks for potential Hormuz dealplaceholder alt text
By Jason MaJuly 25, 2026
Economy
'The demographic dividend of the last 40 years is ending': J.P. Morgan says the world is running out of the two things that kept interest rates downplaceholder alt text
By Eleanor PringleJuly 24, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.